Nechaeva EA - Search Results

1

[4647-cell culture for preparation of recombinant bivaccine against smallpox and hepatitis B].

Skarnovich MO, Radaeva IF, Vdovichenko GV, Nechaeva EA, Sergeev AA, Petrishchenko VA, Pliasunov IV, Shishkina LN, Ternovoĭ VA, Smetannikova MA, Agafonov AP, Sergeev AN. Skarnovich MO, et al. Among authors: nechaeva ea. Vopr Virusol. 2007 Mar-Apr;52(2):37-40. Vopr Virusol. 2007. PMID: 17500238 Russian.

2

[Development and certification of libraries of the MDCK continuous cell line for production of influenza vaccine].

Radaeva IF, Kolokol'tsova TD, Nechaeva EA, Mazurkova NA, Il'ina TV, Getmanova TN, Baltueva LS, Grafodatskiĭ AS, Gendon IuZ, Petruchuk EM. Radaeva IF, et al. Among authors: nechaeva ea. Vopr Virusol. 2005 Mar-Apr;50(2):43-6. Vopr Virusol. 2005. PMID: 15881398 Russian.

3

[Characteristics of continuous cell line 293 used for preparation of antineoplastic agent Cancerolysin].

Radaeva IF, Vdovichenko GV, Sergeev AA, Kolokol'tsova TD, Nechaeva EA, Sergeev AN, Ternovoĭ VA, Netesov SV. Radaeva IF, et al. Among authors: nechaeva ea. Antibiot Khimioter. 2005;50(5-6):7-10. Antibiot Khimioter. 2005. PMID: 16526602 Russian.

4

[Further development (MDCK) of live cold-adapted influenza vaccine: cultivation of vaccine strains in production fermenters].

Gendon IuZ, Markushin SG, Akopova II, Koptiaeva IB, Nechaeva EA, Mazurkova IA, Radaeva IF, Kolokol'tsova TD. Gendon IuZ, et al. Among authors: nechaeva ea. Vopr Virusol. 2005 Mar-Apr;50(2):4-9. Vopr Virusol. 2005. PMID: 15881389 Russian.

5

The use of components of plant origin in the development of production technology for live cold-adapted cultural influenza vaccine.

Mazurkova NA, Kolokol'tsova TD, Nechaeva EA, Shishkina LN, Sergeev AN. Mazurkova NA, et al. Among authors: nechaeva ea. Bull Exp Biol Med. 2008 Jul;146(1):144-7. doi: 10.1007/s10517-008-0223-2. Bull Exp Biol Med. 2008. PMID: 19145373

6

Banks of cell cultures for biotechnology.

Radaeva IF, Bogryantseva MP, Nechaeva EA. Radaeva IF, et al. Among authors: nechaeva ea. Bull Exp Biol Med. 2012 Aug;153(4):581-5. doi: 10.1007/s10517-012-1771-z. Bull Exp Biol Med. 2012. PMID: 22977875 English, Russian.

7

Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine.

Ghendon YZ, Markushin SG, Akopova II, Koptiaeva IB, Nechaeva EA, Mazurkova LA, Radaeva IF, Kolokoltseva TD. Ghendon YZ, et al. Among authors: nechaeva ea. Vaccine. 2005 Sep 7;23(38):4678-84. doi: 10.1016/j.vaccine.2005.04.039. Vaccine. 2005. PMID: 16026905

8

Primary characterization of SARS coronavirus strain Frankfurt 1.

Agafonov AP, Gus'kov AA, Ternovoi VA, Ryabchikova EI, Durymanov AG, Vinogradov IV, Maksimov NL, Ignat'ev GM, Nechaeva EA, Netesov SV. Agafonov AP, et al. Among authors: nechaeva ea. Dokl Biol Sci. 2004 Jan-Feb;394(1):58-60. doi: 10.1023/b:dobs.0000017131.06970.74. Dokl Biol Sci. 2004. PMID: 15088406 Free PMC article. No abstract available.

9

[Development of a live culture of cold-adapted reassortant influenza vaccines].

Gendon IuZ, Markushin SG, Akopova II, Koptiaeva NB, Isachenko AA, Mazurkova NA, Nechaeva EA. Gendon IuZ, et al. Among authors: nechaeva ea. Vopr Virusol. 2003 Mar-Apr;48(2):12-7. Vopr Virusol. 2003. PMID: 12924092 Russian.

10

Enteric administration of a live attenuated measles vaccine does not induce protective immunity in a macaque model.

Stittelaar KJ, de Swart RL, Vos HW, van Amerongen G, Agafonov AP, Nechaeva EA, Osterhaus AD. Stittelaar KJ, et al. Among authors: nechaeva ea. Vaccine. 2002 Jul 26;20(23-24):2906-12. doi: 10.1016/s0264-410x(02)00231-1. Vaccine. 2002. PMID: 12126901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters